Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations

Clinical Endocrinology

Volumn 70, Issue 2, 2009, Pages 259-264

  Igreja, Susana ^a   Chahal, Harvinder S ^a   Akker, Scott A ^a   Gueorguiev, Maria ^a   Popovic, Vera ^b   Damjanovic, Svetozar ^b   Burman, Pia ^c   Wass, John A ^d   Quinton, Richard ^e   Grossman, Ashley B ^a   Korbonits, Márta ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d CHURCHILL HOSPITAL   (United Kingdom)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARYL HYDROCARBON RECEPTOR INTERACTING PROTEIN; CORTICOTROPIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; GENOMIC DNA; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADRENAL HYPERPLASIA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; HYPERPARATHYROIDISM; HYPOPHYSIS ADENOMA; INTRON; MALE; MULTIPLE ENDOCRINE NEOPLASIA; MULTIPLE ENDOCRINE NEOPLASIA GENE; NEUROENDOCRINE TUMOR; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE;

ADULT; AGED; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; GREAT BRITAIN; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PROTO-ONCOGENE PROTEINS; SERBIA;

EID: 58549111025     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03379.x     Document Type: Article

References (43)

1. Marx, S.J., Agarwal, S.K., Kester, M.B. et al. (1999) Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias. Recent Progress in Hormone Research, 54, 397 438.
2. Brandi, M.L., Gagel, R.F., Angeli, A. et al. (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. Journal of Clinical Endocrinology and Metabolism, 86, 5658 5671.
3. Georgitsi, M., Raitila, A., Karhu, A. et al. (2007) Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia. Journal of Clinical Endocrinology and Metabolism, 92, 3321 3325.
4. Pellegata, N.S., Quintanilla-Martinez, L., Siggelkow, H. et al. (2006) Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proceedings of the National Academy of Sciences of USA, 103, 15558 15563.
5. Fritz, A., Walch, A., Piotrowska, K. et al. (2002) Recessive transmission of a multiple endocrine neoplasia syndrome in the rat. Cancer Research, 62, 3048 3051.
6. Ozawa, A., Agarwal, S.K., Mateo, C.M. et al. (2007) The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations. Journal of Clinical Endocrinology and Metabolism, 92, 1948 1951.
7. Leontiou, C.A., Gueorguiev, M., van der, S.J. et al. (2008) The role of the Aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 93, 2390 2401.
8. Toledo, R.A., Lourenco, D.M. Jr., Liberman, B. et al. (2007) Germline mutation in the aryl hydrocarbon receptor interacting protein gene in familial somatotropinoma. Journal of Clinical Endocrinology and Metabolism, 92, 1934 1937.
9. Vierimaa, O., Georgitsi, M., Lehtonen, R. et al. (2006) Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science, 312, 1228 1230.
10. Georgitsi, M., Raitila, A., Karhu, A. et al. (2007) Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations. Proceedings of the National Academy of Sciences of USA, 104, 4101 4105.
11. Daly, A.F., Vanbellinghen, J.F., Khoo, S.K. et al. (2007) Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. Journal of Clinical Endocrinology and Metabolism, 92, 1891 1896.
12. Georgitsi, M., De, M.E., Cannavo, S. et al. (2008) Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas. Clinical Endocrinology, 69, 621 627.
13. Raitila, A., Georgitsi, M., Karhu, A. et al. (2007) No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia. Endocrine-Related Cancer, 14, 901 906.
14. Buchbinder, S., Bierhaus, A., Zorn, M. et al. (2008) Aryl hydrocarbon receptor interacting protein gene (AIP) mutations are rare in patients with hormone secreting or non-secreting pituitary adenomas. Experimental Clinical Endocrinology and Diabetes, doi : 10. 1055/s-2008- 1065366.
15. Cetani, F., Pardi, E., Ambrogini, E. et al. (2007) Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation. Endocrine-Related Cancer, 14, 493 499.
16. Bjerre, P., Gyldensted, C., Riishede, J. et al. (1982) The empty sella and pituitary adenomas. A theory on the causal relationship. Acta Neurologica Scandinavica, 66, 82 92.
17. Bjerre, P. (1990) The empty sella. A reappraisal of etiology and pathogenesis. Acta Neurologica Scandinavica Supplement, 130, 1 25.
18. Robinson, D.B. Michaels, R.D. (1992) Empty sella resulting from the spontaneous resolution of a pituitary macroadenoma. Archives of Internal Medicine, 152, 1920 1923.
19. Weiss, R.E. (2003) Empty sella following spontaneous resolution of a pituitary macroadenoma. Hormone Research, 60, 49 52.
20. Balogh, K., Hunyady, L., Patocs, A. et al. (2007) MEN1 gene mutations in Hungarian patients with multiple endocrine neoplasia type 1. Clinical Endocrinology, 67, 727 734.
21. Kotzerke, J., Oetting, G., Dralle, H. et al. (1989) A young woman with pituitary-tumor, Cushing's syndrome and medullary thyroid carcinoma - a rare case of MEN II? Hormone and Metabolic Research Supplement., 21, 43 45.
22. Marx, S.J. (2005) Molecular genetics of multiple endocrine neoplasia types 1 and 2. Nature Review Cancer, 5, 367 375.
23. Owens, M., Stals, K., Ellard, S. et al. (2008) Germline mutations in the CDKN1B gene encoding p27Kip1 are a rare cause of multiple endocrine neoplasia type 1. Clinical Endocrinology, doi: 10.1111/j.1365-2265.2008.03363.x.
24. Polyak, K., Lee, M.H., Erdjument-Bromage, H. et al. (1994) Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78, 59 66.
25. Nakayama, K., Ishida, N., Shirane, M. et al. (1996) Mice lacking p27 (Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell, 85, 707 720.
26. Dahia, P.L., Aguiar, R.C., Honegger, J. et al. (1998) Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours. Oncogene, 16, 69 76.
27. Jin, L., Qian, X., Kulig, E. et al. (1997) Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries. American Journal of Pathology, 151, 509 519.
28. Lindberg, D., Akerstrom, G. Westin, G. (2007) Mutational analysis of p27 (CDKN1B) and p18 (CDKN2C) in sporadic pancreatic endocrine tumors argues against tumor-suppressor function. Neoplasia, 9, 533 535.
29. Pellegata, N.S., Quintanilla-Martinez, L., Keller, G. et al. (2007) Human pheochromocytomas show reduced p27Kip1 expression that is not associated with somatic gene mutations and rarely with deletions. Virchows Archiv, 451, 37 46.
30. Lauter, K.B. Arnold, A. (2008) Mutational analysis of CDKN1B, a candidate tumor-suppressor gene, in refractory secondary/tertiary hyperparathyroidism. Kidney International, 73, 1137 1140.
31. Lidhar, K., Korbonits, M., Jordan, S. et al. (1999) Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors. Journal of Clinical Endocrinology and Metabolism, 84, 3823 3830.
32. Lloyd, R.V., Jin, L., Qian, X. et al. (1997) Aberrant p27kip1 expression in endocrine and other tumors. American Journal of Pathology, 150, 401 407.
33. Boikos, S.A. Stratakis, C.A. (2007) Molecular genetics of the cAMP-dependent protein kinase pathway and of sporadic pituitary tumorigenesis. Human Molecular Genetics, 16 Spec 1, R80 R87.
34. Komatsubara, K., Tahara, S., Umeoka, K. et al. (2001) Immunohistochemical analysis of p27 (Kip1) in human pituitary glands and in various types of pituitary adenomas. Endocrine Pathology, 12, 181 188.
35. Korbonits, M., Chahal, H.S., Kaltsas, G. et al. (2002) Expression of phosphorylated p27 (Kip1) protein and Jun activation domain-binding protein 1 in human pituitary tumors. Journal of Clinical Endocrinology and Metabolism, 87, 2635 2643.
36. Milne, T.A., Hughes, C.M., Lloyd, R. et al. (2005) Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proceedings of the National Academy of Sciences of USA, 102, 749 754.
37. Karnik, S.K., Hughes, C.M., Gu, X. et al. (2005) Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. Proceedings of the National Academy of Sciences of USA 102, 14659 14664.
38. Beckers, A. Daly, A.F. (2007) The clinical, pathological, and genetic features of familial isolated pituitary adenomas. European Journal of Endocrinology, 157, 371 382.
39. Naves, L.A., Daly, A.F., Vanbellinghen, J.F. et al. (2007) Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene. European Journal of Endocrinology, 157, 383 391.
40. Bell, D.R. Poland, A. (2000) Binding of aryl hydrocarbon receptor (AhR) to AhR-interacting protein. The role of hsp90. Journal of Biological Chemistry, 275, 36407 36414.
41. Bolger, G.B., Peden, A.H., Steele, M.R. et al. (2003) Attenuation of the activity of the cAMP-specific phosphodiesterase PDE4A5 by interaction with the immunophilin XAP2. Journal of Biological Chemistry, 278, 33351 33363.
42. de Oliveira, S.K., Hoffmeister, M., Gambaryan, S. et al. (2007) Phosphodiesterase 2A forms a complex with the co-chaperone XAP2 and regulates nuclear translocation of the aryl hydrocarbon receptor. Journal of Biological Chemistry, 282, 13656 13663.
43. Huang, G. Elferink, C.J. (2005) Multiple mechanisms are involved in Ah receptor-mediated cell cycle arrest. Molecular Pharmacology, 67, 88 96.